Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers-Reference-Cited by-同舟云学术

Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers

Published:2018-06 Issue:3 Volume:11 Page:808-814
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Cesnik Anthony J.,Yang Bing,Truong Andrew,Etheridge Tyler,Spiniello Michele,Steinbrink Maisie I.,Shortreed Michael R.^ORCID,Frey Brian L.^ORCID,Jarrard David F.,Smith Lloyd M.

Funder

National Cancer Institute of the National Institutes of Health

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. PSA and beyond: alternative prostate cancer biomarkers;Saini;Cell Oncol,2016

2. Classification of prostatic carcinomas;Gleason;Cancer Chemother Rep,1966

3. Gleason grading and prognostic factors in carcinoma of the prostate;Humphrey;Mod Pathol,2004

4. Genomic hallmarks of localized, non-indolent prostate cancer;Fraser;Nature,2017

5. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer;Kim;Genome Res,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer;Cancers;2022-12-11

2. MetaNetwork Enhances Biological Insights from Quantitative Proteomics Differences by Combining Clustering and Enrichment Analyses;Journal of Proteome Research;2022-01-24

3. Circulating tumor cells and DNAs in prostate tumors;Liquid Biopsy in Urogenital Cancers and its Clinical Utility;2022

4. The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target;Journal of Drug Targeting;2020-05-25

5. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management;European Urology;2019-11